Preventing hospitalizations for respiratory syncytial virus infection
Robinson, J.L.; Le Saux, N.
Paediatrics and Child Health 20(6): 321-333
2015
ISSN/ISBN: 1205-7088
PMID: 26435673
Accession: 058620650
Le virus respiratoire syncytial est la principale cause d'infection des voies respiratoires inférieures chez les jeunes enfants. Le palivizumab a un effet minime sur le taux d'hospitalisation pour le virus respiratoire syncytial, sauf dans les groupes les plus à risque. Le présent document de principes vise à analyser les publications scientifiques et à formuler des recommandations à jour sur l'utilisation du palivizumab chez les enfants du Canada.
PDF emailed within 1 workday: $29.90
Related References
Benítez-Guerra, D.; Piña-Flores, C.; Zamora-López, M.; Escalante-Padrón, F.; Lima-Rogel, V.; González-Ortiz, A.M.ía.; Guevara-Tovar, M.; Bernal-Silva, S.ía.; Benito-Cruz, B.; Castillo-Martínez, F.; Martínez-Rodríguez, L.E.; Ramírez-Ojeda, V.; Tello-Martínez, N.; Lomelí-Valdez, R.; Salto-Quintana, J.; Cadena-Mota, S.; Noyola, D.E. 2020: Respiratory syncytial virus acute respiratory infection-associated hospitalizations in preterm Mexican infants: a cohort study Influenza and other Respiratory Viruses 14(2): 182-188Naorat, S.; Chittaganpitch, M.; Thamthitiwat, S.; Henchaichon, S.; Sawatwong, P.; Srisaengchai, P.; Lu, Y.; Chuananon, S.; Amornintapichet, T.; Chantra, S.; Erdman, D.D.; Maloney, S.A.; Akarasewi, P.; Baggett, H.C. 2013: Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008-2011 Journal of Infectious Diseases 208 Suppl. 3: S238-S245
Stensballe, L.Graff.; Ravn, H.; Kristensen, K.; Meakins, T.; Aaby, P.; Simoes, E.A.F. 2009: Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus Journal of Pediatrics 154(2): 296-298
Choudhuri, J.A.; Ogden, L.G.; Ruttenber, A.J.; Thomas, D.S.K.; Todd, J.K.; Simoes, E.A.F. 2006: Effect of altitude on hospitalizations for respiratory syncytial virus infection Pediatrics 117(2): 349-356
Singleton, R.J.; Petersen, K.M.; Berner, J.E.; Schulte, E.; Chiu, K.; Lilly, C.M.; Hughes, E.A.; Bulkow, L.R.; Nix, T.L. 1995: Hospitalizations for respiratory syncytial virus infection in Alaska Native children Pediatric Infectious Disease Journal 14(1): 26-30
Moyes, J.; Cohen, C.; Pretorius, M.; Groome, M.; von Gottberg, A.; Wolter, N.; Walaza, S.; Haffejee, S.; Chhagan, M.; Naby, F.; Cohen, A.L.; Tempia, S.; Kahn, K.; Dawood, H.; Venter, M.; Madhi, S.A. 2013: Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011 Journal of Infectious Diseases 208 Suppl. 3: S217-S226
Lanari, M.; Giovannini, M.; Giuffré, L.; Marini, A.; Rondini, G.; Rossi, G.A.; Merolla, R.; Zuccotti, G.V.; Salvioli, G.P. 2002: Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity Pediatric Pulmonology 33(6): 458-465
Wang, E.E.; Tang, N.K. 2000: Immunoglobulin for preventing respiratory syncytial virus infection Cochrane Database of Systematic Reviews 2000(2): Cd001725
Domachowske, J.; Halczyn, J.; Bonville, C.A. 2018: Preventing Pediatric Respiratory Syncytial Virus Infection Pediatric Annals 47(9): E371-E376
Navarro-Marí, J.M.; Palacios Del Valle, E.; Pérez-Ruiz, M.; De La Rosa, M. 2003: The impact of influenza viruses on hospitalizations in infants younger than two years old during epidemics of respiratory syncytial virus infection Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 9(9): 959-963
Moreno-Perez, D.; Calvo, C.; Alfayate Miguélez, S.; Alvarez Alvarez, C.; Álvez González, F.; Arcos Machancoses, J.V.; Arístegui Fernández, J.; Baquero Artigao, F.; Bernaola Iturbe, E.; Bueno Pardo, S.; Cabero Pérez, M.J.; Cabrera Roca, G.; Calvo, C.; Ceballos Rodríguez, I.M.; Cerdán Oncala, S.; Ciria Calavia, L.M.; Couceiro Gianzo, J.A.; de Cea, J.M.; de Juan Martín, F.; Delgado Cardoso, M.; Escudero Bueno, G.M.; Fernández de Sevilla, M.; Fernández Silveira, L.; García Barreiro, M.; García de Miguel, M.J.; García-García, M.L.; Giménez Sánchez, F.; Gimeno Díaz de Atauri, A.; González González, M.; González Sánchez, M.I.; González Tomé, M.I.; González García, B.; Guillén Martín, S.; Hernández Fernández 2014: Epidemiological and clinical data of hospitalizations associated with respiratory syncytial virus infection in children under 5 years of age in Spain: FIVE multicenter study Influenza and other respiratory viruses 8(2): 209-216
Bracht, M.; Heffer, M.; O'Brien, K. 2005: Family teaching toolbox. Preventing respiratory syncytial virus (RSV) infection Advances in Neonatal Care: Official Journal of the National Association of Neonatal Nurses 5(1): 50-51
Gebretsadik, T.; Wu, P.; Carroll, K.; Dupont, W.; Hartert, T. 2017: Preventing Respiratory Syncytial Virus Infection to Prevent Asthma: The Missing Link American Journal of Respiratory and Critical Care Medicine 196(1): 116-117
1998: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 102(3): 531-537
Johnson, T.R.; Graham, B.S. 2004: Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection Pediatric Infectious Disease Journal 23(1 Suppl): S46-S57